Related Experiment Video
Updated: Jun 3, 2025
05:28
Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
481
Associations Between Upper Extremity Function, Activities of Daily Living, and Functional Capacity in Patients with
Aylin Tanrıverdi Eyolcu1, Buse Özcan Kahraman2, Ebru Özpelit3
1Department of Physiotherapy and Rehabilitation, Çankırı Karatekin University, Faculty of Health Sciences, Çankırı, Türkiye.
Summary
Upper extremity function in heart failure with reduced ejection fraction (HFrEF) patients is linked to daily activities and overall capacity. The 6-Minute Pegboard and Ring Test (6PBRT) shows lower physiological strain compared to other common tests.
Area of Science:
- Cardiology
- Rehabilitation Medicine
- Exercise Physiology
Background:
- Heart failure with reduced ejection fraction (HFrEF) significantly impacts patients' functional abilities.
- Limited data exists on the interplay between upper extremity function, activities of daily living (ADLs), and functional capacity in HFrEF.
Purpose of the Study:
- To investigate the associations between upper extremity function, ADLs, and functional capacity in patients diagnosed with HFrEF.
Main Methods:
- A cross-sectional study involving 31 HFrEF patients.
- Evaluated upper extremity function with the 6-Minute Pegboard and Ring Test (6PBRT).
- Assessed ADLs using the Glittre Activities of Daily Living Test (TGlittre) and functional capacity via the 6-Minute Walk Test (6MWT).
Main Results:
- Significant correlations were observed between 6PBRT performance and both TGlittre (rho = -0.718) and 6-minute walk distance (6MWD) (r = 0.546).
- Strong association found between TGlittre and 6MWD (rho = -0.810).
- Physiological responses (heart rate, blood pressure, dyspnea) differed significantly across the tested activities.
Conclusions:
- Upper extremity function is demonstrably associated with ADLs and functional capacity in HFrEF patients.
- The 6PBRT presents a lower cardiopulmonary demand compared to TGlittre and 6MWT for this population.
More Related Videos
Related Concept Videos
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381